Peter R. Donald

13.8k total citations · 2 hit papers
193 papers, 9.9k citations indexed

About

Peter R. Donald is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Peter R. Donald has authored 193 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Infectious Diseases, 101 papers in Epidemiology and 86 papers in Surgery. Recurrent topics in Peter R. Donald's work include Tuberculosis Research and Epidemiology (120 papers), Infectious Diseases and Tuberculosis (65 papers) and Pneumocystis jirovecii pneumonia detection and treatment (39 papers). Peter R. Donald is often cited by papers focused on Tuberculosis Research and Epidemiology (120 papers), Infectious Diseases and Tuberculosis (65 papers) and Pneumocystis jirovecii pneumonia detection and treatment (39 papers). Peter R. Donald collaborates with scholars based in South Africa, United States and United Kingdom. Peter R. Donald's co-authors include H. Simon Schaaf, Ben J. Marais, Nulda Beyers, Robert P. Gie, Andreas H. Diacon, Johan F. Schoeman, Anneke C. Hesseling, Paul D. van Helden, Amour Venter and Rodney Dawson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Peter R. Donald

192 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculous meningitis: a uniform case definition for use in clinical research

2010 616 citations Johan F. Schoeman, Peter R. Donald et al. profile →
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

2004 607 citations Ben J. Marais, H. Simon Schaaf et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter R. Donald South Africa	57	7.4k	5.0k	4.8k	1.1k	1.0k	193	9.9k
H. Simon Schaaf South Africa	57	9.5k 1.3×	6.7k 1.3×	5.2k 1.1×	298 0.3×	619 0.6×	324	11.6k
Gary Maartens South Africa	62	10.4k 1.4×	6.5k 1.3×	3.2k 0.7×	232 0.2×	709 0.7×	376	14.0k
Graeme Meintjes South Africa	65	9.3k 1.3×	8.8k 1.7×	3.7k 0.8×	576 0.5×	630 0.6×	304	12.6k
David T. Durack United States	43	5.4k 0.7×	6.0k 1.2×	1.4k 0.3×	400 0.4×	1.1k 1.1×	99	11.4k
Hansjakob Furrer Switzerland	64	9.2k 1.2×	5.6k 1.1×	929 0.2×	262 0.2×	707 0.7×	276	14.3k
Reinout van Crevel Netherlands	54	6.5k 0.9×	4.3k 0.9×	2.2k 0.5×	556 0.5×	1.7k 1.7×	221	11.8k
Rob E. Aarnoutse Netherlands	45	4.5k 0.6×	2.9k 0.6×	1.3k 0.3×	241 0.2×	730 0.7×	194	6.6k
Giovanni Battista Migliori Italy	65	10.2k 1.4×	7.4k 1.5×	4.3k 0.9×	129 0.1×	1.7k 1.7×	351	13.7k
Timothy R. Sterling United States	51	9.1k 1.2×	6.6k 1.3×	3.5k 0.7×	105 0.1×	724 0.7×	244	11.6k
Christian Lienhardt United Kingdom	46	5.1k 0.7×	3.6k 0.7×	1.7k 0.3×	129 0.1×	896 0.9×	133	6.8k

Countries citing papers authored by Peter R. Donald

Since Specialization

Citations

This map shows the geographic impact of Peter R. Donald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Donald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Donald more than expected).

Fields of papers citing papers by Peter R. Donald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Donald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Donald. The network helps show where Peter R. Donald may publish in the future.

Co-authorship network of co-authors of Peter R. Donald

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Donald. A scholar is included among the top collaborators of Peter R. Donald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Donald. Peter R. Donald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garcia‐Prats, Anthony J., H. Simon Schaaf, Maxwell Chirehwa, et al.. (2022). Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 66(6). e0226421–e0226421. 1 indexed citations

Donald, Peter R. & Ronald van Toorn. (2016). Use of corticosteroids in tuberculous meningitis. The Lancet. 387(10038). 2585–2587. 7 indexed citations

Diacon, Andreas H., Rodney Dawson, Florian von Groote-Bidlingmaier, et al.. (2015). Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline. American Journal of Respiratory and Critical Care Medicine. 191(8). 943–953. 165 indexed citations

Diacon, Andreas H. & Peter R. Donald. (2014). The early bactericidal activity of antituberculosis drugs. Expert Review of Anti-infective Therapy. 12(2). 223–237. 37 indexed citations

Diacon, Andreas H., J. S. Maritz, Amour Venter, et al.. (2011). Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clinical Microbiology and Infection. 18(7). 711–717. 52 indexed citations

Donald, Peter R., et al.. (2011). Pyrazinamide pharmacokinetics and efficacy in adults and children. Tuberculosis. 92(1). 1–8. 26 indexed citations

Diacon, Andreas H., Rodney Dawson, M. Hanekom, et al.. (2011). Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. The International Journal of Tuberculosis and Lung Disease. 15(7). 949–954. 157 indexed citations

Donald, Peter R. & H. Simon Schaaf. (2007). Old and new drugs for the treatment of tuberculosis in children. Paediatric Respiratory Reviews. 8(2). 134–141. 30 indexed citations

Schaaf, H. Simon, Ben J. Marais, Andrew Whitelaw, et al.. (2007). Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infectious Diseases. 7(1). 140–140. 110 indexed citations

10.

Sirgel, F A, P. Bernard Fourie, Peter R. Donald, et al.. (2005). The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 172(1). 128–135. 83 indexed citations

11.

Schoeman, J. F., et al.. (2001). The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Annals of Tropical Paediatrics. 21(4). 299–305. 26 indexed citations

12.

Vandenplas, Michel L., et al.. (1998). Distribution of acetylator genotypes in the coloured population of the Western Cape region of South Africa. South African Journal of Science. 94(8). 404–406. 2 indexed citations

13.

Donald, Peter R., et al.. (1998). Intensive short course chemotherapy in the management of tuberculous meningitis.. PubMed. 2(9). 704–11. 62 indexed citations

14.

Beyers, Nulda, et al.. (1997). Adenylate Kinase Activity in the Cerebrospinal Fluid of Children with Tuberculous Meningitis and its Relationship to Neurological Outcome. Scandinavian Journal of Infectious Diseases. 29(3). 275–280. 3 indexed citations

15.

Seifart, H. I., et al.. (1995). Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen. Annals of Tropical Paediatrics. 15(3). 249–254. 13 indexed citations

16.

Donald, Peter R., H. I. Seifart, D. P. Parkin, & P. P. Van Jaarsveld. (1994). Hydrazine Production in Children Receiving Isoniazid for the Treatment of Tuberculous Meningitis. Annals of Pharmacotherapy. 28(12). 1340–1343. 5 indexed citations

17.

Donald, Peter R., J. F. Schoeman, Mark F. Cotton, & Lana E. Van Zyl. (1991). Cerebrospinal fluid investigations in tuberculous meningitis. Annals of Tropical Paediatrics. 11(3). 241–246. 18 indexed citations

18.

Donald, Peter R., et al.. (1990). Criteria for the notification of childhood tuberculosis in a high-incidence area of the western Cape Province.. PubMed. 77(8). 385–6. 20 indexed citations

19.

Donald, Peter R. & R Cooper. (1987). Enzyme-linked immunosorbent assay for the detection of mycobacterial antigens in the cerebrospinal fluid in tuberculous meningitis.. PubMed. 71(11). 699–700. 2 indexed citations

20.

Donald, Peter R., et al.. (1983). Simultaneous determination of cerebrospinal fluid glucose and blood glucose concentrations in the diagnosis of bacterial meningitis. The Journal of Pediatrics. 103(3). 413–415. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact